Villanova Investment Management Co LLC bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 61,800 shares of the medical instruments supplier's stock, valued at approximately $1,173,000.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Nordea Investment Management AB boosted its position in shares of DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after purchasing an additional 178,639 shares during the period. JPMorgan Chase & Co. boosted its position in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after buying an additional 1,244,326 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after buying an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after acquiring an additional 35,360 shares in the last quarter. Finally, Barclays PLC increased its holdings in shares of DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after purchasing an additional 54,920 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts recently commented on XRAY shares. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Evercore ISI reaffirmed an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Morgan Stanley lowered their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research note on Tuesday, December 17th. Barrington Research reduced their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Finally, StockNews.com downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus target price of $23.33.
Read Our Latest Report on XRAY
DENTSPLY SIRONA Stock Performance
Shares of DENTSPLY SIRONA stock traded down $0.04 on Friday, reaching $13.58. The stock had a trading volume of 4,877,929 shares, compared to its average volume of 2,926,758. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.54 and a fifty-two week high of $33.02. The business's 50-day moving average price is $17.25 and its two-hundred day moving average price is $19.89. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market cap of $2.70 billion, a P/E ratio of -6.56, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.
DENTSPLY SIRONA Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.71%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.
Insider Buying and Selling
In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.52% of the stock is owned by insiders.
DENTSPLY SIRONA Company Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.